4.5 Review

Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells

期刊

STEM CELLS INTERNATIONAL
卷 2013, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2013/724360

关键词

-

资金

  1. American University of Beirut Medical Practice Plan and University Research Board
  2. Lebanese National Council for Scientific Research
  3. Lady TATA Memorial Trust
  4. French-Lebanese inter-governmental Program CEDRE
  5. Qatar National Research Fund

向作者/读者索取更多资源

Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder. Current targeted therapies designed to inhibit the tyrosine kinase activity of the BCR-ABL oncoprotein have made a significant breakthrough in the treatment of CML patients. However, CML remains a chronic disease that a patient must manage for life. Although tyrosine kinase inhibitors (TKI) therapy has completely transformed the prognosis of CML, it has made the therapeutic management more complex. The interruption of TKI treatment results in early disease progression because it does not eliminate quiescent CML stem cells which remain a potential reservoir for disease relapse. This highlights the need to develop new therapeutic strategies for CML to achieve a permanent cure, and to allow TKI interruption. This review summarizes recent research done on alternative targeted therapies with a particular focus on some important signaling pathways (such as Alox5, Hedgehog, Wnt/b-catenin, autophagy, and PML) that have the potential to target CML stem cells and potentially provide cure for CML.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据